Global Cancer Immunotherapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Immune Checkpoint Inhibitors
1.4.4 Immune System Modulators
1.4.5 Cancer Vaccines
1.5 Market by Application
1.5.1 Global Cancer Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Lung Cancer
1.5.3 Breast Cancer
1.5.4 Colorectal Cancer
1.5.5 Melanoma
1.5.6 Prostate Cancer
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Immunotherapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Cancer Immunotherapy Industry
1.6.1.1 Cancer Immunotherapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cancer Immunotherapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cancer Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Cancer Immunotherapy Market Perspective (2015-2026)
2.2 Cancer Immunotherapy Growth Trends by Regions
2.2.1 Cancer Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Cancer Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Immunotherapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Players by Market Size
3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Immunotherapy Market Concentration Ratio
3.2.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2019
3.3 Cancer Immunotherapy Key Players Head office and Area Served
3.4 Key Players Cancer Immunotherapy Product Solution and Service
3.5 Date of Enter into Cancer Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Cancer Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2021-2026)
5 Cancer Immunotherapy Breakdown Data by Application (2015-2026)
5.1 Global Cancer Immunotherapy Market Size by Application (2015-2020)
5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Immunotherapy Market Size (2015-2020)
6.2 Cancer Immunotherapy Key Players in North America (2019-2020)
6.3 North America Cancer Immunotherapy Market Size by Type (2015-2020)
6.4 North America Cancer Immunotherapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Immunotherapy Market Size (2015-2020)
7.2 Cancer Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe Cancer Immunotherapy Market Size by Type (2015-2020)
7.4 Europe Cancer Immunotherapy Market Size by Application (2015-2020)
8 China
8.1 China Cancer Immunotherapy Market Size (2015-2020)
8.2 Cancer Immunotherapy Key Players in China (2019-2020)
8.3 China Cancer Immunotherapy Market Size by Type (2015-2020)
8.4 China Cancer Immunotherapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Immunotherapy Market Size (2015-2020)
9.2 Cancer Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan Cancer Immunotherapy Market Size by Type (2015-2020)
9.4 Japan Cancer Immunotherapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Immunotherapy Market Size (2015-2020)
10.2 Cancer Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Immunotherapy Market Size by Application (2015-2020)
11 India
11.1 India Cancer Immunotherapy Market Size (2015-2020)
11.2 Cancer Immunotherapy Key Players in India (2019-2020)
11.3 India Cancer Immunotherapy Market Size by Type (2015-2020)
11.4 India Cancer Immunotherapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Immunotherapy Market Size (2015-2020)
12.2 Cancer Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Cancer Immunotherapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview and Its Total Revenue
13.1.3 Amgen Cancer Immunotherapy Introduction
13.1.4 Amgen Revenue in Cancer Immunotherapy Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca Cancer Immunotherapy Introduction
13.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview and Its Total Revenue
13.3.3 Roche Cancer Immunotherapy Introduction
13.3.4 Roche Revenue in Cancer Immunotherapy Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview and Its Total Revenue
13.4.3 Bayer Cancer Immunotherapy Introduction
13.4.4 Bayer Revenue in Cancer Immunotherapy Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction
13.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview and Its Total Revenue
13.6.3 Eli Lilly Cancer Immunotherapy Introduction
13.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview and Its Total Revenue
13.7.3 Merck Cancer Immunotherapy Introduction
13.7.4 Merck Revenue in Cancer Immunotherapy Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview and Its Total Revenue
13.8.3 Novartis Cancer Immunotherapy Introduction
13.8.4 Novartis Revenue in Cancer Immunotherapy Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Cancer Immunotherapy Introduction
13.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2015-2020)
13.9.5 Pfizer Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Cancer Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Immunotherapy Revenue
Table 3. Ranking of Global Top Cancer Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Immune Checkpoint Inhibitors
Table 7. Key Players of Immune System Modulators
Table 8. Key Players of Cancer Vaccines
Table 9. COVID-19 Impact Global Market: (Four Cancer Immunotherapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Cancer Immunotherapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Cancer Immunotherapy Players to Combat Covid-19 Impact
Table 14. Global Cancer Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Cancer Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Cancer Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Cancer Immunotherapy Market Share by Regions (2015-2020)
Table 18. Global Cancer Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Cancer Immunotherapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Cancer Immunotherapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Cancer Immunotherapy Players
Table 25. Global Cancer Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Cancer Immunotherapy Market Share by Players (2015-2020)
Table 27. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy as of 2019)
Table 28. Global Cancer Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Cancer Immunotherapy Product Solution and Service
Table 31. Date of Enter into Cancer Immunotherapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 34. Global Cancer Immunotherapy Market Size Share by Type (2015-2020)
Table 35. Global Cancer Immunotherapy Revenue Market Share by Type (2021-2026)
Table 36. Global Cancer Immunotherapy Market Size Share by Application (2015-2020)
Table 37. Global Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Cancer Immunotherapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 41. North America Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 42. North America Cancer Immunotherapy Market Share by Type (2015-2020)
Table 43. North America Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Cancer Immunotherapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 47. Europe Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Cancer Immunotherapy Market Share by Type (2015-2020)
Table 49. Europe Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Cancer Immunotherapy Market Share by Application (2015-2020)
Table 51. China Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 53. China Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 54. China Cancer Immunotherapy Market Share by Type (2015-2020)
Table 55. China Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Cancer Immunotherapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 59. Japan Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Cancer Immunotherapy Market Share by Type (2015-2020)
Table 61. Japan Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Cancer Immunotherapy Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 65. Southeast Asia Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Cancer Immunotherapy Market Share by Type (2015-2020)
Table 67. Southeast Asia Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Cancer Immunotherapy Market Share by Application (2015-2020)
Table 69. India Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 70. India Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 71. India Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 72. India Cancer Immunotherapy Market Share by Type (2015-2020)
Table 73. India Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 74. India Cancer Immunotherapy Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Cancer Immunotherapy Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Cancer Immunotherapy Market Share (2019-2020)
Table 77. Central & South America Cancer Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Cancer Immunotherapy Market Share by Type (2015-2020)
Table 79. Central & South America Cancer Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Cancer Immunotherapy Market Share by Application (2015-2020)
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Product
Table 94. Roche Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 95. Roche Recent Development
Table 96. Bayer Company Details
Table 97. Bayer Business Overview
Table 98. Bayer Product
Table 99. Bayer Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 100. Bayer Recent Development
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Product
Table 109. Eli Lilly Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 110. Eli Lilly Recent Development
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Product
Table 114. Merck Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 115. Merck Recent Development
Table 116. Novartis Business Overview
Table 117. Novartis Product
Table 118. Novartis Company Details
Table 119. Novartis Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 120. Novartis Recent Development
Table 121. Pfizer Company Details
Table 122. Pfizer Business Overview
Table 123. Pfizer Product
Table 124. Pfizer Revenue in Cancer Immunotherapy Business (2015-2020) (Million US$)
Table 125. Pfizer Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cancer Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Immune System Modulators Features
Figure 5. Cancer Vaccines Features
Figure 6. Global Cancer Immunotherapy Market Share by Application: 2020 VS 2026
Figure 7. Lung Cancer Case Studies
Figure 8. Breast Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Cancer Immunotherapy Report Years Considered
Figure 14. Global Cancer Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Cancer Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 16. Global Cancer Immunotherapy Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Cancer Immunotherapy Market Share by Players in 2019
Figure 19. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2019
Figure 21. North America Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Cancer Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 30. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 34. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 38. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 40. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 42. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 44. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed